Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.
Bibliographical note© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.
- Atrial fibrillation
- Atrial flutter
- Electrical cardioversion
- Pharmacological cardioversion